AMYT.L Regulatory News (AMYT)

Fastnet Equity plc

("Fastnet" or the "Company")

Result of General Meeting and Change of Name

18 April 2016, London - Further to the announcement on 31 March 2016 in relation to the Proposals, the Directors are pleased to announce that all resolutions proposed at the General Meeting of the Company held earlier today were approved. Consequently the Acquisition will now proceed and accordingly the Company's name will change to Amryt Pharma plc ("Amryt"). Following the change of name, the Company's ticker will change to 'AMYT' on AIM and 'AYP' on the ESM.

Following the Capital Reorganisation, the Company's ISIN and SEDOL will change to GB00BDD1LS57 and BDD1LS5, respectively. It is expected that the New Ordinary Shares arising as a result of the Capital Reorganisation in respect of Existing Ordinary Shares held in uncertificated form, i.e. in CREST, will be credited to the relevant CREST accounts on 19 April 2016.

Trading on AIM and the ESM of the Existing Ordinary Shares of the Company will be cancelled, and re-admission and dealings in New Ordinary Shares in Amryt will commence on AIM and ESM, at 8.00 a.m. on 19 April 2016.

Terms used in this announcement shall have the meanings given to them in the Company's admission document dated 31 March 2016.

The Admission Document is available on the Company's website www.amrytpharma.com

For further information, please contact: